BDNF
Drug reverses aging-associated changes in brain cells
Drugs that affect the levels of an important brain protein involved in learning and memory reverse cellular changes in the brain seen during aging, according to an animal study in the December 7 issue of The Journal of Neuroscience. T…
Promising MS drug increases neuroprotection
Laquinimod is an orally available synthetic compound that has been successfully evaluated in phase II/III clinical studies for the treatment of relapsing-remitting multiple sclerosis (RRMS). The mechanism of act…
Fasting forestalls Huntington's disease in mice
Decreasing meal frequency and caloric intake protects nerve cells from genetically induced damage, delays the onset of Huntington’s disease-like symptoms in mice, and prolongs the lives of affected rodents, according to investigators at the National Institute on Aging (NIA) Intramural Research Program. This animal study* is the first to suggest that a change in diet can influence the course of Huntington’s disease.